MCM
GOSS icon

Moore Capital Management’s Gossamer Bio GOSS Stock Holding History

Moore Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,363
Closed -$1.23M – 791
2021
Q4 		$1.23M Sell
1,363
-42
-3% -$39.9K 0.02% 443
2021
Q3 		$1.41M Buy
+1,405
New +$1.03M 0.02% 488

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Moore Capital Management's GOSS Position: Q1 2022 in Review

Moore Capital Management sold out of Gossamer Bio (GOSS) in Q1 2022, closing a stake of 1,363 shares — an estimated $1.23M sold.

Moore Capital Management first reported a position in GOSS in Q3 2021 and held it in 2 quarters. The position peaked at $1.41M in Q3 2021. 139 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

  • Moore Capital Management reported no remaining Gossamer Bio position as of Q1 2022 after selling out during the quarter.
  • Moore Capital Management sold 1,363 Gossamer Bio shares in Q1 2022, an estimated $1.23M.
  • Moore Capital Management first reported a position in Gossamer Bio in Q3 2021 and held it in 2 quarters.
  • Moore Capital Management's Gossamer Bio position peaked at $1.41M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on Moore Capital Management's 13F filing for Q1 2022, filed 16 May 2022.